CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 12, 2008
Clin J Am Soc Nephrol 4: 77-85, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.03720708

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.03720708v1
4/1/77    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agarwal, R.
Right arrow Articles by Tegegne, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, R.
Right arrow Articles by Tegegne, G. G.

Diagnosis

Assessment of Iothalamate Plasma Clearance: Duration of Study Affects Quality of GFR

Rajiv Agarwal, Jennifer E. Bills, Paulos M. Yigazu, Terri Abraham, Andinet B. Gizaw, Robert P. Light, Dagim M. Bekele, and Getachew G. Tegegne

Indiana University School of Medicine and Veterans Administration Medical Center, Indianapolis, Indiana

Correspondence: Dr. Rajiv Agarwal, Professor of Medicine, Indiana University and Veterans Administration Medical Center, 1481 West 10th Street, Indianapolis, IN 46202. Phone 317-988-2241; Fax: 317-988-2171; E-mail: ragarwal{at}iupui.edu

Background and objectives: Measurement of GFR is important for the management of chronic kidney disease (CKD). Although bolus administration of radiocontrast agents is commonly used to measure GFR, the optimal duration of sampling to assess their plasma clearance is unknown. The purpose of this study was to evaluate whether the duration of plasma sampling influences precision and estimation of GFR.

Design, setting, participants, & measurements: GFR was measured by sampling plasma 12 times over 5 h in 56 patients with CKD (mean age 64 yr, 98% men, 79% Caucasian, 34% diabetics, estimated GFR 31.8 ± 14.2 ml/min/1.73 m2). In a subset of 12 patients we measured GFR by sampling plasma 17 times over 10 h.

Results: Short sampling intervals considerably overestimated GFR measured using total plasma iothalamate clearance, especially in larger patients. In the higher estimated GFR group (>30 ml/min/1.73m2), the 5-h GFR was 17% higher and 2-h GFR 54% higher compared with the 10-h GFR, which averaged 40.3 ml/min/1.73 m2. In the lower estimated GFR group (<30 ml/min/1.73m2), the 5-h GFR was 36% higher and 2-h GFR 126% higher compared with the 10-h GFR, which averaged 22.2 ml/min/1.73 m2. Short sampling duration also reduced the precision of the estimated GFR from 1.67% for 10-h GFR, to 3.48% for 5-h GFR, and to 7.07% for 2-h GFR.

Conclusions: GFR measured over a longer duration with multiple plasma samples spanning the distribution and elimination phases may improve precision and provide a better measure of renal function.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
L. A. Stevens and A. S. Levey
Measured GFR as a Confirmatory Test for Estimated GFR
J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2305 - 2313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.